Vicadrostat by Boehringer Ingelheim International for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval

Vicadrostat is under clinical development by Boehringer Ingelheim International and currently in Phase III for Chronic Kidney Disease (Chronic Renal Failure).

KFF Health News’ ‘What the Health?’: The long road to reining in short-term plans

It took more than two years, but the Biden administration has finally kept a promise made by then-candidate Joe Biden to roll back the Trump

July 13, 2023

Conservative justices stir trouble for Republican politicians on abortion

Abortion opponents have maneuvered in courthouses for years to end access to reproductive health care. In Arizona last week, a win for the anti-abortion camp

April 16, 2024

CDC: Cases of MIS-C After COVID Still Occurring in U.S. Kids

Cases of multisystem inflammatory syndrome in children (MIS-C) are still popping up, but at lower rates than those observed early in the COVID-19 pandemic, CDC

March 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.